Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 337-348 of 1,136
Drug study icon
Not Yet RecruitingNCT07405606

Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Addiction

This study is looking at whether Psilocybin 25 mg can help people with depression or Addiction. Participants take part in Psilocybin 25 mg and complete follow-up assessments.

Remote / online
Depression, AddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression, Addiction
Drug study icon
Not Yet RecruitingNCT06546358

Quetiapine Versus Trazadone in Women With Postpartum Depression

This study is looking at whether a digital support tool can help people with Postpartum Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In Canada
DepressionDrugFrom 18 Years to 45 Years
Countries
Canada
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition
Depression
Other study type icon
Not Yet RecruitingNCT07317895

Sensitivity to Ovarian Hormones and Depression in Adolescents

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

Remote / online
DepressionOtherFrom 12 Years to 18 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07434973

Stratification and Treatment in Early Psychosis Study - PROMOTE

This study is looking at whether Cannabidiol (CBD) can help people with Clinical High Risk for Psychosis or Clinical High Risk for Developing Psychosis. Participants take part in Cannabidiol (CBD) and complete follow-up assessments.

In Canada
SchizophreniaDrugFrom 12 Years to 35 Years
Countries
Canada, United Kingdom, Switzerland, ...
Sponsor
University of Oxford
Condition
Schizophrenia
Drug study icon
Not Yet RecruitingNCT07262008

Sustained Mood Improvement With Laughing Gas Exposure

This study is looking at whether questionnaires and follow-up can help people with depression or Treatment Resistant Depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In Canada
DepressionDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Women's College Hospital
Condition
Depression
Drug study icon
Not Yet RecruitingNCT06651112

The ATP Project (Antipsychotic-TEP-Psychosis)

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In Canada
SchizophreniaDrugFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Université de Sherbrooke
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT07429357

The REWIRE Behaviour Study

This study is looking at whether psychoeducation can help people with anxiety or depression or Social Media. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

Remote / online
Anxiety, DepressionBehavioralFrom 12 Years to 17 Years
Countries
Canada
Sponsor
Gary Goldfield
Condition
Anxiety, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.